US Executive Officer Management Changes SEC — June 10, 2026

10-06-2026

Syndax Pharmaceuticals held its 2026 Annual Meeting on June 10, 2026, where stockholders approved the 2026 Equity Incentive Plan (reserving 7,200,000 shares) and the 2026 Employee Stock Purchase Plan, both effective immediately. The 2026 Plan replaces the expired 2015 Omnibus Incentive Plan, and the 2026 ESPP does not carry over shares from the 2015 ESPP. All director nominees were elected, and all five proposals passed, though the 2026 Plan received a relatively narrow approval margin (33.3M for vs. 25.4M against).

• · The 2026 Plan includes share recycling provisions from the 2015 Plan's outstanding awards.
• · The 2026 ESPP has two components: a Section 423 qualified component for U.S. employees and a non-qualified component for foreign employees.
• · Shares available under the 2015 ESPP will not roll over to the 2026 ESPP.
• · The 2026 Plan received a relatively narrow approval with 33,333,263 votes for and 25,392,051 against (excluding broker non-votes).
• · All other proposals passed with strong majorities: advisory say-on-pay (55.7M for), auditor ratification (66.6M for), and 2026 ESPP (58.7M for).

10-06-2026

EquipmentShare.com Inc (EQPT) announced the appointment of Damian Giangiacomo and Harley Miller to its Board of Directors, effective June 8, 2026, following the completion of its IPO. Concurrently, board members Henry Yeagley and John Weinstein stepped down as part of an orderly board transition. The changes reflect the company's evolution as a public company, with Giangiacomo bringing corporate governance and finance expertise and Miller contributing deep historical knowledge of the company.

• · Damian Giangiacomo will serve on the Audit Committee of the Board.
• · Henry Yeagley joined the Board in May 2022; John Weinstein joined in December 2024.
• · Harley Miller previously served on EquipmentShare's Board from December 2016 during its private growth phase.
• · Damian Giangiacomo co-founded Nexus Capital Management LP in 2013, which has approximately $5 billion in assets under management.
• · Harley Miller founded Left Lane Capital in 2019 and previously spent nine years as a Principal at Insight Venture Management, LLP.
• · John Weinstein stated that Insight Partners remains a dedicated shareholder.

10-06-2026

Purebase Corporation announced the appointment of Dr. Amy T. Clemens as Chief Financial Officer, effective June 5, 2026. Dr. Clemens previously served as interim CFO for two years during the company's inception and returns from the defense industry. The filing does not disclose any financial metrics or performance data, so no period-over-period comparisons or quantitative trends are available.

• · Dr. Clemens previously served as interim CFO for 2 years during Purebase's inception before returning to the defense industry.
• · The appointment is effective June 5, 2026.
• · The company describes itself as a 'highly diversified mineral resource company' and a 'diversified resource company' that acquires, develops and markets high-value minerals and agricultural products.

10-06-2026

Aldeyra Therapeutics appointed Darlene Deptula-Hicks to its board of directors on June 9, 2026. Ms. Deptula-Hicks brings over 30 years of experience in public and private life sciences, including senior executive and CFO roles, and will support the company's progress toward potential commercialization of therapies for immune-mediated diseases. The filing does not disclose any financial results or performance metrics, so no period-over-period comparisons are available.

• · Ms. Deptula-Hicks currently serves as acting CFO of Normunity Inc., a clinical-stage cancer biotech.
• · She previously served as CFO of F-star Therapeutics, Inc.
• · Aldeyra's product candidates include RASP modulators ADX-248, ADX-246, and reproxalap (for dry eye disease and allergic conjunctivitis), and ADX-2191 (intravitreal methotrexate for primary vitreoretinal lymphoma and retinitis pigmentosa).

10-06-2026

Metagenomi Therapeutics, Inc. (MGX) announced the resignation of board member Brian C. Thomas, Ph.D., effective June 9, 2026, with no disagreement cited. At the same time, the company held its 2026 annual meeting, where stockholders elected Juergen Eckhardt and Eric Bjerkholt as Class II directors and ratified PricewaterhouseCoopers LLP as the independent auditor for fiscal 2026. The meeting had a quorum of 19,116,207 shares (50.8% of outstanding shares), but the director elections saw significant broker non-votes (10,382,607) and relatively low 'for' votes, indicating potential shareholder disengagement.

• · The director election had 10,382,607 broker non-votes for both nominees, representing 54.3% of the quorum shares.
• · Eric Bjerkholt received 8,251,289 'for' votes (94.5% of votes cast excluding broker non-votes), while Juergen Eckhardt received 7,296,718 'for' votes (83.5% of votes cast excluding broker non-votes).
• · Ratification of PricewaterhouseCoopers LLP passed overwhelmingly with 18,483,295 'for' votes (99.7% of votes cast).
• · The record date for the annual meeting was April 13, 2026, and the proxy statement was filed on April 27, 2026.

10-06-2026

Reborn Coffee, Inc. announced the appointment of Jung Jae Lim as Chief Executive Officer, effective immediately, following the departure of Jay Kim as Co-Chief Executive Officer on June 4, 2026. The Board expressed confidence in Mr. Lim's leadership and stated the transition will not impact operations, expansion plans, franchise development, or financial reporting. No financial figures or performance metrics were disclosed in the filing.

• · Jung Jae Lim had served as Co-Chief Executive Officer and Director since March 2026 before assuming full CEO role.
• · The Board affirmed no impact on day-to-day operations, domestic/international expansion, franchise development, or financial reporting obligations.
• · The filing includes forward-looking statements cautioning about risks including the Company's ability to continue as a going concern due to recurring net losses.

10-06-2026

Trane Technologies announced the appointment of Donny Simmons as Chief Operating Officer, effective July 1, 2026, reporting to Chair and CEO Dave Regnery. The move aligns leadership structure with the company's increased scale and expanding market opportunities, as Trane has nearly doubled annual revenue since 2020. No negative or flat performance metrics were disclosed in this filing.

• · Simmons previously served as Group President of the Americas region, overseeing commercial and residential HVAC, transport refrigeration, and life science solutions.
• · Simmons joined the company in 2001 and has led Commercial HVAC North America, EMEA, and several global industrial businesses.
• · Simmons has experience across general management, sales, manufacturing, and finance.

10-06-2026

Industrial Logistics Properties Trust (ILPT) held its 2026 annual meeting on June 9, 2026, where all seven trustee nominees were elected, and shareholders voted in favor of an annual non-binding advisory vote on executive compensation. The Board also expanded from seven to eight members and elected Elena B. Poptodorova as an Independent Trustee, effective immediately. While all director nominees received majority support, Lisa Harris Jones and Adam Portnoy each received over 8.3 million withhold votes (approximately 29% of votes cast), indicating notable shareholder dissent.

• · The Board increased its size from seven to eight members to accommodate the new trustee.
• · Elena B. Poptodorova was appointed to the Audit, Compensation, and Nominating and Governance Committees.
• · Ms. Poptodorova has served as a trustee of Office Properties Income Trust since 2017 and previously served as a director of TravelCenters of America Inc. until its acquisition by BP in May 2023.
• · She was the Bulgarian ambassador to the United States from 2002-2008 and 2010-2016.
• · The company entered into an indemnification agreement with Ms. Poptodorova on substantially the same terms as with other trustees and executive officers.
• · Broker non-votes totaled 21,001,576 on all director elections and advisory proposals (except auditor ratification).
• · The auditor ratification received 49,402,172 For votes with only 255,510 Against and 47,959 Abstain, and no broker non-votes.
• · The Board determined to hold an annual non-binding advisory vote on executive compensation, consistent with the shareholder vote.

10-06-2026

Wheels Up Experience Inc. held its 2026 Annual Meeting on June 9, 2026, with 92.6% of outstanding shares represented. Stockholders approved all four proposals, including the election of four Class II directors, advisory approval of executive compensation, ratification of Grant Thornton LLP as auditor, and an amendment to the 2021 Long-Term Incentive Plan to increase available shares from 3,007,484 to 6,757,484 (post-reverse split) and extend the plan termination date to March 31, 2036. The filing reflects routine governance actions with strong shareholder support, though broker non-votes were significant on certain proposals.

• · The 1-for-20 reverse stock split became effective after market close on April 24, 2026.
• · The LTIP Amendment was previously approved by the Board and Compensation Committee on March 31, 2026.
• · Broker non-votes totaled 39,845,045 shares on director elections, executive compensation, and the LTIP Amendment.
• · Ratification of Grant Thornton LLP received 544,018,799 votes for, 3,043,148 against, and 587,022 abstentions (no broker non-votes).
• · The LTIP termination date was extended to March 31, 2036.

10-06-2026

LB Pharmaceuticals Inc announced that Chief Medical Officer Dr. Anna Eramo will resign effective June 15, 2026, for personal reasons, and transition to an advisor role through September 15, 2026. The company stated the departure is unrelated to clinical program operations and does not expect a material impact on clinical development activities or milestones. A search for a replacement is underway, and the company has experienced clinical teams to oversee ongoing trials.

• · Dr. Eramo will receive her current base salary on a monthly basis until June 15, 2027, if she remains engaged as a consultant through September 15, 2026.
• · She will receive 100% of her target annual bonus for 2026 on a prorated basis.
• · The company will reimburse COBRA healthcare premium costs for up to 12 months following the Separation Date.
• · The Separation Agreement includes confidentiality and non-disparagement covenants and a release of claims.

10-06-2026

Astrana Health, Inc. held its 2026 Annual Meeting on June 10, 2026, where stockholders approved the Amended and Restated 2024 Equity Incentive Plan, increasing the reserved shares by 1,000,000 and extending the plan term to March 24, 2036. All nine director nominees were elected, Ernst & Young LLP was ratified as independent auditor, and the advisory vote on executive compensation passed. However, director J. Lorraine Estradas received the highest number of withheld votes (3,244,703) among nominees, indicating some shareholder dissent.

• · The record date for the annual meeting was April 14, 2026.
• · Broker non-votes totaled 8,356,118 on all director elections and on Proposals 3 and 4.
• · Proposal 2 (ratification of auditor) had no broker non-votes and passed with 43,722,509 votes for, 19,566 against, and 30,520 abstentions.
• · The advisory vote on executive compensation (Proposal 3) received 34,119,199 for, 1,209,072 against, and 88,206 abstentions.
• · The 2024 Plan approval (Proposal 4) received 34,679,879 for, 701,303 against, and 35,295 abstentions.
• · Director J. Lorraine Estradas had the highest withheld votes (3,244,703) among all nominees.
• · Director John Chiang received the most votes for (34,104,046) among nominees.

10-06-2026

Eikon Therapeutics appointed Ma. Fatima D. Francisco as a Class I director effective June 15, 2026, with an annual retainer of $50,000 and an option to purchase 85,937 shares at $8.96 per share. No other material changes were disclosed.

• · Ms. Francisco will serve on the Compensation Committee.
• · Option vests in 48 equal monthly installments subject to continued service.
• · Ms. Francisco entered into standard indemnification agreement.
• · No arrangements or understandings with other persons regarding her selection.
• · No related person transactions required to be disclosed.

10-06-2026

Apple Hospitality REIT, Inc. announced that Elizabeth S. Perkins, Senior Vice President and Chief Financial Officer, has been appointed as the Company's principal accounting officer effective June 10, 2026, succeeding Rachel Labrecque, who passed away on June 9, 2026.

• · Ms. Perkins assumed the additional role of principal accounting officer on June 10, 2026.
• · Ms. Labrecque's passing occurred on June 9, 2026.
• · Ms. Perkins' biographical information is incorporated by reference from the Company's definitive proxy statement filed on April 2, 2026.

10-06-2026

Vir Biotechnology, Inc. announced the appointment of Timothy Coughlin, CPA, to its Board of Directors, increasing the Board size from seven to eight members. Mr. Coughlin will serve as a Class III director and Chair of the Audit Committee, effective immediately. He will receive standard non-employee director compensation, including stock option and restricted stock unit grants under the 2019 Equity Incentive Plan.

• · Mr. Coughlin was not selected pursuant to any arrangement or understanding, and no related party transactions exist under Item 404(a) of Regulation S-K.
• · The appointment is effective immediately, with Mr. Coughlin's term running until the 2028 annual meeting of stockholders.
• · Standard form indemnity agreement entered into with Mr. Coughlin, referenced from the Company's 2019 Form S-1 filing.
• · No prior period data or comparisons are provided; this is a single-event filing.

10-06-2026

Sensei Biotherapeutics, Inc. filed a Certificate of Amendment to its Amended and Restated Certificate of Incorporation, increasing its authorized capital stock from 210,000,000 shares to 310,000,000 shares, consisting of 300,000,000 shares of Common Stock and 10,000,000 shares of Preferred Stock. The amendment was approved by the Board and stockholders, and became effective upon filing with the Delaware Secretary of State on June 10, 2026. This corporate action provides the company with additional authorized shares for potential future financing, acquisitions, or other strategic purposes.

• · The Certificate of Incorporation was originally filed on December 1, 2017 under the name PPI Holdings, Inc.
• · Previous amendments were filed on December 29, 2020, February 8, 2021, and June 12, 2025.
• · The par value for both Common Stock and Preferred Stock remains $0.0001 per share.
• · The amendment was adopted in accordance with Section 242 of the DGCL.

10-06-2026

Sleep Number Corporation elected Colin M. Adams as a director on June 4, 2026, effective immediately. The Board now comprises 7 members, 6 of whom are independent under Nasdaq standards. Mr. Adams will receive a monthly fee of $40,000 for his service, with potential additional fees for extra activities.

• · No arrangement or understanding existed between Mr. Adams and any other person regarding his selection as a director.
• · No transactions requiring disclosure under Item 404(a) of Regulation S-K were reported.

10-06-2026

Broadridge Financial Solutions appointed Todd Diganci to its Board of Directors effective August 1, 2026, expanding the board to 10 members, eight of whom are independent. Diganci, former EVP, CFO, and CAO of FINRA, will serve on the Audit Committee. The appointment brings regulatory and financial expertise to support Broadridge's innovation and growth.

• · Broadridge processes over 7 billion communications annually and underpins daily average trading of over $15 trillion in tokenized and traditional securities globally.
• · Broadridge is part of the S&P 500 Index and employs over 15,000 associates in 21 countries.

10-06-2026

Perpetua Resources Corp. filed an 8-K on June 10, 2026, disclosing the adoption of the 2026 Equity Incentive Plan and related award agreements (RSU, PSU, DSU) effective June 2026. The filing also covers director/officer changes under Items 5.02 and 5.07, though specific departures or elections are not detailed in the provided content. No financial figures or period-over-period comparisons are included.

• · The 8-K includes Items 5.02 (Director/Officer Departure/Election), 5.07 (Submission of Matters to a Vote of Security Holders), 8.01 (Other Events), and 9.01 (Financial Statements and Exhibits).
• · Exhibits filed include the 2026 Equity Incentive Plan and forms of RSU, PSU, and DSU Award Agreements.
• · The report is signed by Mark Murchison, Chief Financial Officer, dated June 10, 2026.

10-06-2026

Fervo Energy (Nasdaq: FRVO) announced the promotion of Sarah Jewett to Chief Operating Officer (COO), effective June 10, 2026. Jewett, who joined the company in 2020 and previously led the strategy department, will oversee centralized corporate operations as the company accelerates its standardized geothermal development model. The filing highlights the company's growing project pipeline across utility offtake, AI hyperscaler demand, and industrial power applications, but provides no financial metrics or period-over-period comparisons.

• · Sarah Jewett spent her twenties running hydraulic fracturing crews for Schlumberger across the Permian, North Slope, and Western U.S. basins.
• · She holds an M.B.A. from Harvard Business School and a Bachelor of Engineering in Mechanical Engineering from Dartmouth College.
• · Jewett joined Fervo in 2020 to lead the strategy department after working at Select Energy Services.
• · The COO role is newly created to centralize supply chain, land, permitting, policy, and people functions as the company scales.

10-06-2026

Credit Acceptance Corporation announced the appointment of Joe Billante as Chief Financial Officer, effective July 27, 2026, succeeding Jay Martin, who will retire after 23 years with the company. Billante brings over 25 years of finance leadership experience from Barracuda Networks, eBay, and General Electric. As part of a planned transition, Martin will participate in Q2 earnings and remain engaged through August 31, 2026.

• · Billante served as CFO of Barracuda Networks, leading global finance through strategic transformation.
• · At eBay, Billante spent 13 years in senior roles including CFO for European and Greater China businesses and VP of Investor Relations.
• · Billante began his career at General Electric, including as CFO of a global division of GE Healthcare.
• · Jay Martin joined Credit Acceptance in 2003 and will remain actively engaged through August 31, 2026.
• · Martin will participate in the Q2 earnings call alongside management as part of the transition.

10-06-2026

Tandy Leather Factory Inc. (TLF) disclosed in an 8-K filing that its Board approved increases to non-employee director cash retainers to $20,000, with additional fees for committee chairs and members, and accelerated vesting of all unvested RSUs effective June 9, 2026. The Board also appointed John Gehre as Chairman. At the annual meeting, all six director nominees were elected with strong support (over 4.3 million votes for each), and the ratification of Whitley Penn as auditor passed with 5,622,340 votes for versus 627,286 against. The advisory vote on executive compensation received 4,370,852 votes for and 455,754 against, indicating shareholder approval but with notable dissent.

• · All six director nominees received over 4.3 million votes for, with withheld votes ranging from 431,346 to 433,434.
• · Broker non-votes totaled 1,420,087 for each director election and for the advisory vote on executive compensation.
• · Ratification of Whitley Penn as auditor had 5,622,340 votes for, 627,286 against, and 1,000 abstentions.
• · Advisory vote on executive compensation: 4,370,852 for, 455,754 against, 3,933 abstentions.
• · The Board accelerated vesting of all unvested RSUs as of June 9, 2026; future RSUs will vest at grant date.

10-06-2026

American Airlines Group Inc. held its 2026 Annual Meeting on June 10, 2026, where stockholders approved the amended and restated 2023 Incentive Award Plan (increasing shares reserved by 16.5 million), ratified KPMG as independent auditor, and elected all 12 director nominees. However, stockholders did not approve a proposal to limit officer liability, nor two stockholder proposals on written consent and cumulative voting.

• · Stockholders did NOT approve the proposal to amend the Restated Certificate of Incorporation to limit officer liability — 270,464,196 For, 22,139,185 Against, 968,316 Abstain; failed to achieve majority of shares outstanding.
• · Stockholder proposal for right to act by written consent failed: 59,402,069 For vs. 232,549,168 Against.
• · Stockholder proposal for cumulative voting failed: 10,018,677 For vs. 281,843,732 Against.
• · All 12 director nominees were elected; Martin H. Nesbitt received the highest number of Against votes (32,817,804) among nominees.
• · Ratification of KPMG as auditor passed overwhelmingly: 438,670,632 For, 9,494,939 Against.
• · Advisory vote on executive compensation (Say-on-Pay) passed with 284,141,512 For, 8,637,705 Against.
• · Broker non-votes totaled 155,803,612 shares on all non-routine proposals.

10-06-2026

On June 8, 2026, DeFi Development Corp. announced the resignation of Parker White as Chief Operating Officer and Chief Investment Officer. The company entered into a separation agreement providing $250,000 in cash payments over twelve months and accelerated vesting of 213,272 unvested stock options, while also engaging Mr. White for consulting services at $8,333 per month.

• · The Separation Agreement includes a release of claims against the company.
• · Mr. White's consulting services will focus on transition of operations of certain validators owned by the company.
• · The effective date of resignation and separation is June 8, 2026.
• · The filing is dated June 10, 2026.

10-06-2026

Crocs, Inc. held its 2026 annual meeting on June 9, 2026, where stockholders approved the new 2026 Equity Incentive Plan, replacing the 2020 Plan, and ratified Deloitte & Touche LLP as independent auditor for fiscal 2026. All three Class III director nominees (Thomas J. Smach, Beth J. Kaplan, Neeraj S. Tolmare) were elected. The advisory vote on executive compensation (say-on-pay) was also approved. However, the 2026 Equity Incentive Plan received a notable 22.2% vote against (7,830,864 shares), indicating significant shareholder dissent.

• · The 2026 Equity Incentive Plan replaces the 2020 Plan; no further awards will be made under the 2020 Plan after the effective date.
• · The Plan allows for incentive and non-qualified stock options, stock appreciation rights, performance units, restricted stock, restricted stock units, and other stock or cash-based awards.
• · All three Class III director nominees were elected with over 31.5 million votes for each, but Thomas J. Smach received the highest withheld vote count (3,693,557).
• · Ratification of Deloitte & Touche LLP passed with 98.4% of votes cast in favor.
• · Say-on-pay passed with 97.6% of votes cast in favor (excluding broker non-votes).

10-06-2026

On June 5, 2026, SecureTech Innovations, Inc. appointed Anthony Vang as full-time Chief Financial Officer, formalizing the financial leadership role he has held since the company's inception in 2017. Mr. Vang will continue to serve without compensation until

10-06-2026

On June 5, 2026, Yelp Inc. held its Annual Meeting where all nine director nominees were elected with at least 96.9% votes in favor, stockholders ratified Deloitte & Touche LLP as auditor for FY2026, approved advisory say-on-pay with 93.7% support, and approved an amendment to the Employee Stock Purchase Plan (ESPP) increasing available shares by 2,100,000. Subsequently, on June 8, Chief Product Officer Craig Saldanha notified his resignation effective July 3, 2026, with Senior Vice President of Product Akhil Kuduvalli Ramesh appointed as successor.

• · The ESPP amendment was adopted by the Compensation Committee on April 10, 2026, and became effective June 5, 2026.
• · Craig Saldanha notified his resignation on June 8, 2026, with effective date July 3, 2026, after more than four years with Yelp.
• · The advisory say-on-pay resolution received 93.7% support, the lowest approval percentage among all proposals.
• · All nine directors were re-elected to serve until the 2027 Annual Meeting.
• · Broker non-votes totaled 6,466,581 for each director proposal and the say-on-pay and ESPP proposals, but none for the auditor ratification.

10-06-2026

Seven Hills Realty Trust (SEVN) announced the resignation of Independent Trustee Jeffrey P. Somers effective June 9, 2026, and the election of Mark A. Talley as his replacement. At the annual meeting, shareholders elected three trustees (Ann M. Danner, William A. Lamkin, Matthew P. Jordan) and ratified Deloitte & Touche LLP as independent auditors for fiscal 2026. No financial results or period-over-period comparisons were provided in this filing.

• · Shareholder votes for trustees: Ann M. Danner (12,668,995 for, 1,063,799 withhold), William A. Lamkin (11,708,471 for, 2,024,323 withhold), Matthew P. Jordan (13,097,434 for, 635,360 withhold). Broker non-votes: 5,333,706 for each.
• · Ratification of Deloitte & Touche LLP as auditors: 18,380,982 for, 542,376 against, 143,142 abstain.
• · Mark A. Talley will serve on the Audit, Compensation, and Nominating and Governance Committees.
• · Mr. Talley was a principal and founding partner of Greenwood Commercial Real Estate from 2021 to 2023 and founded Griswold Realty Advisors in 2012.

10-06-2026

Entrada Therapeutics held its 2026 Annual Meeting on June 10, 2026, where stockholders elected two Class II directors (Peter S. Kim, Ph.D. and Bernhardt Zeiher, M.D.), ratified Ernst & Young as auditor, and approved amendments to the 2021 Stock Option and Incentive Plan and the 2021 Employee Stock Purchase Plan. The amendments modify the evergreen provision to include outstanding pre-funded warrants in the share count for calculating annual increases. While director elections and auditor ratification passed with strong support, the equity plan amendments received significant opposition (39.4% and 30.8% against, respectively, excluding broker non-votes), indicating notable shareholder dissent.

• · The 2021 Plan Amendment received 14,686,713 votes FOR, 9,566,186 AGAINST, and 6,562 abstentions, with 8,930,773 broker non-votes.
• · The 2021 ESPP Amendment received 16,780,217 votes FOR, 7,475,514 AGAINST, and 3,730 abstentions, with 8,930,773 broker non-votes.
• · Auditor ratification passed overwhelmingly with 33,132,550 FOR, 49,650 AGAINST, and 8,034 abstentions.
• · The amendments adjust the evergreen formula to include outstanding pre-funded warrants in the share count for calculating annual increases under both plans.

10-06-2026

SIGA Technologies held its 2026 annual meeting on June 9, 2026, where stockholders approved an amendment to the 2010 Stock Incentive Plan, increasing authorized shares from 8.5 million to 15 million, and elected eight director nominees. While all proposals passed, the stock plan amendment received notable opposition with 12,390,841 votes against and 20,559 abstentions, and there were 11,201,471 broker non-votes on three proposals.

• · The stock plan amendment (Proposal 4) passed with 38,823,234 votes for, 12,390,841 against, and 20,559 abstentions, indicating significant shareholder opposition.
• · Broker non-votes totaled 11,201,471 on Proposals 1, 2, and 4.
• · Ratification of PricewaterhouseCoopers as auditor passed overwhelmingly with 62,040,317 votes for, 343,043 against, and 52,745 abstentions.
• · The non-binding advisory vote on executive compensation passed with 48,744,042 for, 2,404,456 against, and 86,136 abstentions.

10-06-2026

ZoomInfo Technologies Inc. disclosed in an 8-K filing on June 10, 2026 that its Compensation Committee approved a performance-based cash bonus for CFO Michael Graham O’Brien with a target award value of $500,000 for FY2026. The actual payout will range from 0% to 150% of the target, based on achievement of adjusted operating income goals established by the Committee, determined after the fiscal year-end financial statements are finalized.

• · The performance-based cash bonus was unanimously approved by the Compensation Committee on June 5, 2026.
• · The performance goals are based on fiscal year 2026 adjusted operating income goals established by the Committee.
• · The actual payout will be determined after the fiscal year 2026 financial statements are finalized.

10-06-2026

UFP Technologies announced the appointment of Ryan Stafford as General Counsel and Senior Vice President of Human Resources effective June 4, 2026, succeeding Chris Litterio who is retiring. Stafford brings nearly three decades of legal and HR leadership experience from Littelfuse and Tyco International, aligning with the company's growth strategy.

• · Stafford began his legal career as an associate at Sulloway & Hollis, a New Hampshire law firm.
• · Stafford earned a Bachelor of Arts in History and German from Bowdoin College and a Juris Doctor from the University of Maine School of Law.
• · The company operates in segments including robotic assisted surgery, patient beds, infection control, cardiovascular, orthopedics and spine, and wound care.